Gupta Yask, Friedman David J, McNulty Michelle, Khan Atlas, Lane Brandon, Wang Chen, Ke Juntao, Jin Gina, Wooden Benjamin, Knob Andrea L, Lim Tze Y, Appel Gerald B, Huggins Kinsie, Liu Lili, Mitrotti Adele, Stangl Megan C, Bomback Andrew, Westland Rik, Bodria Monica, Marasa Maddalena, Shang Ning, Cohen David J, Crew Russell J, Morello William, Canetta Pietro, Radhakrishnan Jai, Martino Jeremiah, Liu Qingxue, Chung Wendy K, Espinoza Angelica, Luo Yuan, Wei Wei-Qi, Feng Qiping, Weng Chunhua, Fang Yilu, Kullo Iftikhar J, Naderian Mohammadreza, Limdi Nita, Irvin Marguerite R, Tiwari Hemant, Mohan Sumit, Rao Maya, Dube Geoffrey, Chaudhary Ninad S, Gutiérrez Orlando M, Judd Suzanne E, Cushman Mary, Lange Leslie A, Lange Ethan M, Bivona Daniel L, Verbitsky Miguel, Winkler Cheryl A, Kopp Jeffrey B, Santoriello Dominick, Batal Ibrahim, Brant Pinheiro Sérgio Veloso, Araújo Oliveira Eduardo, E Silva Ana Cristina Simoes, Pisani Isabella, Fiaccadori Enrico, Lin Fangming, Gesualdo Loreto, Amoroso Antonio, Ghiggeri Gian Marco, D'Agati Vivette D, Magistroni Riccardo, Kenny Eimear E, Loos Ruth J F, Montini Giovanni, Hildebrandt Friedhelm, Paul Dirk S, Petrovski Slavé, Goldstein David B, Kretzler Matthias, Gbadegesin Rasheed, Gharavi Ali G, Kiryluk Krzysztof, Sampson Matthew G, Pollak Martin R, Sanna-Cherchi Simone
medRxiv. 2023 Aug 4:2023.08.02.23293554. doi: 10.1101/2023.08.02.23293554.
Black Americans have a significantly higher risk of developing chronic kidney disease (CKD), especially focal segmental glomerulosclerosis (FSGS), than European Americans. Two coding variants (G1 and G2) in the gene play a major role in this disparity. While 13% of Black Americans carry the high-risk recessive genotypes, only a fraction of these individuals develops FSGS or kidney failure, indicating the involvement of additional disease modifiers. Here, we show that the presence of the p.N264K missense variant, when co-inherited with the G2 risk allele, substantially reduces the penetrance of the G1G2 and G2G2 high-risk genotypes by rendering these genotypes low-risk. These results align with prior functional evidence showing that the p.N264K variant reduces the toxicity of the high-risk alleles. These findings have important implications for our understanding of the mechanisms of -associated nephropathy, as well as for the clinical management of individuals with high-risk genotypes that include the G2 allele.
与欧裔美国人相比,非裔美国人患慢性肾脏病(CKD)尤其是局灶节段性肾小球硬化症(FSGS)的风险显著更高。该基因中的两个编码变体(G1和G2)在这种差异中起主要作用。虽然13%的非裔美国人携带高风险隐性基因型,但这些个体中只有一小部分会发展为FSGS或肾衰竭,这表明还有其他疾病修饰因子参与其中。在此,我们表明,当p.N264K错义变体与G2风险等位基因共同遗传时,通过使这些基因型变为低风险,可大幅降低G1G2和G2G2高风险基因型的外显率。这些结果与先前的功能证据一致,即p.N264K变体可降低高风险等位基因的毒性。这些发现对于我们理解与该基因相关的肾病机制以及对包括G2等位基因在内的高风险基因型个体的临床管理具有重要意义。